IBDEI0UY ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14241,1,3,0)
 ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14241,1,4,0)
 ;;=4^E11.351
 ;;^UTILITY(U,$J,358.3,14241,2)
 ;;=^5002640
 ;;^UTILITY(U,$J,358.3,14242,0)
 ;;=E11.359^^82^775^71
 ;;^UTILITY(U,$J,358.3,14242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14242,1,3,0)
 ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14242,1,4,0)
 ;;=4^E11.359
 ;;^UTILITY(U,$J,358.3,14242,2)
 ;;=^5002641
 ;;^UTILITY(U,$J,358.3,14243,0)
 ;;=E11.341^^82^775^72
 ;;^UTILITY(U,$J,358.3,14243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14243,1,3,0)
 ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14243,1,4,0)
 ;;=4^E11.341
 ;;^UTILITY(U,$J,358.3,14243,2)
 ;;=^5002638
 ;;^UTILITY(U,$J,358.3,14244,0)
 ;;=E11.349^^82^775^73
 ;;^UTILITY(U,$J,358.3,14244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14244,1,3,0)
 ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14244,1,4,0)
 ;;=4^E11.349
 ;;^UTILITY(U,$J,358.3,14244,2)
 ;;=^5002639
 ;;^UTILITY(U,$J,358.3,14245,0)
 ;;=E11.9^^82^775^74
 ;;^UTILITY(U,$J,358.3,14245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14245,1,3,0)
 ;;=3^Type 2 DM w/o Complications
 ;;^UTILITY(U,$J,358.3,14245,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,14245,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,14246,0)
 ;;=H35.363^^82^775^18
 ;;^UTILITY(U,$J,358.3,14246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14246,1,3,0)
 ;;=3^Drusen of Macular,Bilateral
 ;;^UTILITY(U,$J,358.3,14246,1,4,0)
 ;;=4^H35.363
 ;;^UTILITY(U,$J,358.3,14246,2)
 ;;=^5005660
 ;;^UTILITY(U,$J,358.3,14247,0)
 ;;=H35.362^^82^775^19
 ;;^UTILITY(U,$J,358.3,14247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14247,1,3,0)
 ;;=3^Drusen of Macular,Left Eye
 ;;^UTILITY(U,$J,358.3,14247,1,4,0)
 ;;=4^H35.362
 ;;^UTILITY(U,$J,358.3,14247,2)
 ;;=^5005659
 ;;^UTILITY(U,$J,358.3,14248,0)
 ;;=H35.361^^82^775^20
 ;;^UTILITY(U,$J,358.3,14248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14248,1,3,0)
 ;;=3^Drusen of Macular,Right Eye
 ;;^UTILITY(U,$J,358.3,14248,1,4,0)
 ;;=4^H35.361
 ;;^UTILITY(U,$J,358.3,14248,2)
 ;;=^5005658
 ;;^UTILITY(U,$J,358.3,14249,0)
 ;;=H04.123^^82^775^21
 ;;^UTILITY(U,$J,358.3,14249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14249,1,3,0)
 ;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
 ;;^UTILITY(U,$J,358.3,14249,1,4,0)
 ;;=4^H04.123
 ;;^UTILITY(U,$J,358.3,14249,2)
 ;;=^5004465
 ;;^UTILITY(U,$J,358.3,14250,0)
 ;;=H35.32^^82^775^28
 ;;^UTILITY(U,$J,358.3,14250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14250,1,3,0)
 ;;=3^Exudative Age-Related Macular Degeneration
 ;;^UTILITY(U,$J,358.3,14250,1,4,0)
 ;;=4^H35.32
 ;;^UTILITY(U,$J,358.3,14250,2)
 ;;=^5005648
 ;;^UTILITY(U,$J,358.3,14251,0)
 ;;=H35.023^^82^775^29
 ;;^UTILITY(U,$J,358.3,14251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14251,1,3,0)
 ;;=3^Exudative Retinopathy,Bilateral
 ;;^UTILITY(U,$J,358.3,14251,1,4,0)
 ;;=4^H35.023
 ;;^UTILITY(U,$J,358.3,14251,2)
 ;;=^5005588
 ;;^UTILITY(U,$J,358.3,14252,0)
 ;;=H35.022^^82^775^30
 ;;^UTILITY(U,$J,358.3,14252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14252,1,3,0)
 ;;=3^Exudative Retinopathy,Left Eye
 ;;^UTILITY(U,$J,358.3,14252,1,4,0)
 ;;=4^H35.022
 ;;^UTILITY(U,$J,358.3,14252,2)
 ;;=^5005587
 ;;^UTILITY(U,$J,358.3,14253,0)
 ;;=H35.021^^82^775^31
 ;;^UTILITY(U,$J,358.3,14253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14253,1,3,0)
 ;;=3^Exudative Retinopathy,Right Eye
 ;;^UTILITY(U,$J,358.3,14253,1,4,0)
 ;;=4^H35.021
